Allergan Aesthetics
SKINVIVE
FDA-Approved Skin-Quality Injectable
SKINVIVE by JUVÉDERM in Seoul, by Allergan Aesthetics (AbbVie). FDA-approved (May 2023) as an HA microdroplet injectable indicated to improve cheek skin smoothness.

Board-Certified Dermatologist
Dr. SangYoul Yun
AAD International Fellow
IFAAD
- Duration
- 20-30 min
- Sessions
- 1 every 3-6 months
- Downtime
- Minimal (24-48 hr mild bumps)

SKINVIVE Treatment in Seoul
- Duration
- 20–30 min
- Sessions
- 1 every 3–6 months
- Downtime
- Minimal (24–48 hr mild bumps)
- Peak Result
- 1 month
Results Over Time
SKINVIVE by JUVÉDERM is an HA microdroplet skin-quality injectable that improves cheek smoothness and hydration from within.
1Immediately post
Small injection papules and mild redness typically resolve within 24–48 hours.
2Days 1–2
Faint bumps and mild tenderness may persist; most patients cover with makeup from Day 2.
3Week 1
Injection marks fully settle; early smoothness and hydration benefits become apparent.
41 month
The FDA pivotal trial (P110033/S059) assessed its primary cheek-smoothness endpoint at this 1-month timepoint.
53–6 months
Skin-quality benefits sustained through 6 months in trial; gradual return to baseline thereafter.
SKINVIVE by JUVÉDERM
Allergan Aesthetics' SKINVIVE is FDA-approved (PMA P110033/S059, May 2023) as an HA microdroplet injectable to improve cheek skin smoothness.

HA Microdroplet Technology
A modified HA formulation delivered as micro-droplets into the skin for smoothness and deep hydration, not volumizing.
Single Treatment
A single session with results building over 2–4 weeks and sustained through ~6 months in clinical trial.
FDA-Approved Indication
FDA-approved to improve cheek skin smoothness.
Treatment Process
1Skin Assessment
The dermatologist evaluates skin quality and hydration needs.
2Precise Injection
SKINVIVE micro-droplets are injected into the cheeks using a fine needle.
3Quick Treatment
Treatment covers both cheeks in approximately 15–20 minutes.
4Visible Results
Results are immediate, with continued improvement over 2–4 weeks.
Treatment explained
How SKINVIVE is injected into the cheek dermis
SKINVIVE is a hyaluronic acid gel injected into the dermis of the cheek.
Film guide (1–8)
What the numbers show
- 1. Outlined cheek area
- 2. Example injection point
- 3. Needle
- 4. Epidermis
- 5. Dermis
- 6. Subcutaneous fat
- 7. Gel at the needle tip
- 8. Injected gel
In the film
- At the marked point on the cheek, the needle tip touches the skin.
- The needle tip sits in the dermis.
- The gel is injected into the dermis.
- The blue shape represents the injected gel.
Recovery & Care
First 24 hours
Avoid vigorous exercise, alcohol, and heat (saunas, hot showers) to minimize bruising and swelling.
Days 2–3
Makeup may be applied once injection marks settle; use gentle cleansers. Avoid massaging the treated area.
Week 1
Continue daily broad-spectrum SPF 30+. Resume normal skincare and exercise.
6-month maintenance
Effects sustained through ~6 months per trial; schedule maintenance at 4–6 months for continuous benefit.

Frequently Asked Questions
Q.Is SkinVive the same as Juvéderm filler?
No. SkinVive is a different product formulated specifically for skin quality improvement, not volumizing. It uses a modified HA formulation designed for micro-droplet injection into the skin.
Q.How long does SkinVive last?
Clinical studies show results lasting up to 6 months from a single treatment. Most patients report noticeable improvement for 3-6 months.
References1
The clinical claims on this page (device specs, efficacy timelines, safety profile) are supported by the primary sources below. Each citation links to the original paper or regulatory record.
- [1]SKINVIVE by JUVÉDERM Premarket Approval (P110033/S059). U.S. Food & Drug Administration (PMA P110033/S059) (2023).
Notice
- Active skin infections or open wounds in the target area
- History of severe or multiple allergies / anaphylaxis
- Known hypersensitivity to hyaluronic acid or gram-positive bacterial proteins
- Bleeding disorders or use of anticoagulants without physician clearance
- Pregnancy or breastfeeding (not studied, avoid as precaution)
Session summary & comparison
| Item | Details |
|---|---|
| Treatment time | About 15-20 minutes (both cheeks) |
| Sessions | Single session; results last 3-6 months |
| Pain & comfort | Fine-needle intradermal micro-droplets across the cheeks |
| Downtime | Minimal: mild redness and small bumps settle within 24-48 hours; avoid heavy exercise and alcohol for 24 hours |
| Onset of results | Immediate, with continued improvement over 2-4 weeks |
| Regulatory status | FDA-approved (May 2023) as an HA microdroplet injectable to improve skin smoothness of the cheeks |
Updated
Related procedures
Evidence & comparison guides
Need another answer before deciding?
You do not need to read every guide. Open the question that still matters to your decision.
Optional decision guides
- Interactive routeFit a dermatologist visit into your itineraryCompare a day trip, overnight visit, or longer stay by travel buffer and typical visible recovery.Open the trip planner →
- Comparison guideSculptra vs Skin Boosters Seoul | Evidence-Based GuideCompare Sculptra with Rejuran PN, Skinvive and Profhilo by treatment goal, published evidence, U.S. FDA status and practical questions to ask in Seoul.
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step



